Envarsus XR 1 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB26FQ82P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,148
Award facts
- Contract value 100% obligated
- $2,148.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,148.10 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Envarsus XR 1 mg tablets (100 count). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by November 24, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Envarsus XR is a brand-name immunosuppressant medication used primarily in transplant patients to prevent organ rejection.
This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems globally. The delivery order exemplifies the company's role as a critical supplier within the federal medical supply chain, fulfilling specific pharmaceutical procurement needs for the Department of Defense and supporting organizations such as the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB26FQ82P?
SPE2DB26FQ82P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FQ82P worth?
The government has obligated $2,148 on SPE2DB26FQ82P.
Is contract SPE2DB26FQ82P an order under another contract?
Yes. SPE2DB26FQ82P is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ82P competed?
The extent of competition for SPE2DB26FQ82P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award